Open AccessIntravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
Author(s) -
N. Vegas-Revenga,
J. L. Martín-Varillas,
V. Calvo-Río,
I. González-Mazón,
L. Sánchez-Bilbao,
E. Beltrán,
Alejandro Fonollosa,
O. Maíz,
Ana Blanco,
Miguel CorderoComa,
N. Ortego,
I. Torre,
Félix Francisco Hernández,
Santiago MuñozFernández,
María Mar Esteban Ortega,
M. Díaz-Llopis,
J. Cañal,
Jose Enrique Lopez Ventosa,
Rosalía DemetrioPablo,
Mario Agudo-Bilbao,
L Domínguez-Casas,
José L. Hernández,
Santos Castañeda,
Miguel A. GonzálezGay,
R. Blanco
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/imrgo2
Subject(s) - medicine , retinal vasculitis , uveitis , methylprednisolone , macular edema , visual acuity , ophthalmology , intermediate uveitis , acute retinal necrosis , vasculitis , retinitis , surgery , anterior uveitis , disease , immunology , virus , human cytomegalovirus
Rapid control of intraocular inflammation in non-infectious uveitis (NIU) is mandatory to avoid irreversible structural and functional damage. In this study, we assessed the efficacy and safety of intravenous methylprednisolone (IVMP) pulses in the treatment of NIU.